Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Wiener Medizinische Wochenschrift (1946)|August 15, 1990
[Predictors of multiple sclerosis development trends with special reference to "questionable initial manifestations"]S Koppi, P Panayiotou, G S BarolinWiener Medizinische Wochenschrift (1946)|January 1, 1991
[15-year-factor analysis of multiple sclerosis]S Koppi, P Panayiotou, G S BarolinJournal of Neurology, Neurosurgery, and Psychiatry|June 1, 1991
Central motor conduction in a family with hereditary motor and sensory neuropathy with pyramidal signs (HMSN V)A Schnider, C W Hess, S KoppiImmunology Letters|January 1, 1984
A two-chain tumour-related suppressor factor specific for a sequence antigenT A Koppi-Reynolds, W J HallidayWiener Medizinische Wochenschrift (1946)|January 1, 1996
[Transcranial magnetic stimulation in depressed patients: a new antidepressive therapeutic principle? Presentation of a pilot trial]S Koppi, A Conca, E Swoboda, et al.Seminars in Oncology Nursing|September 30, 2018
Interprofessional Collaboration: The Future of Publishing in OncologySamantha Karlin, Eleanor Olson, Amelia Robert, et al.Journal of the National Cancer Institute|October 1, 1982
Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factorsW J Halliday, T A Koppi, I F McKenzieNeuropsychobiology|January 1, 1987
Calcium-channel-blocking agent in the treatment of acute alcohol withdrawal--caroverine versus meprobamate in a randomized double-blind studyS Koppi, G Eberhardt, R Haller, et al.Journal of the National Cancer Institute|June 1, 1981
Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors. II. Nature of blocking and unblocking factors in serumT A Koppi, W J Halliday, I F McKenzieOncology|January 1, 1984
Suppression by serum of immunoreactivity to a common tumour antigen in cancer patientsT A Koppi, J M Khan, W J HallidayPageof 4